Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
You guys ROCK!! I LOVE seeing everyone work as a TEAM to contribute so investors, and future investors can look at the stickies, make a cool, calm, educated decision on BLEG $BLEG!
What a run on sentence lol!!
Respectfully,
Maverick
$BLEG
FANTASTIC DTGoody!! Great work! We have SOLID GROUP of investors here!!
TEAMWORK makes the DREAMWORK!!
$BLEG
BLEG
Respectfully,
Maverick
Tomorrow we breakout of this triangle and blow past $1.70
$BREA
BREA
Respectfully,
Maverick
I’m so happy I’ve picked up another 865,000 shares at .019 at the ask, adding to the pile!!
Enjoying these cheap prices and this is a LONG TERM STOCK for me!
We are in at the infancy of a MEGA COMPANY BEING BUILT from ground up, with precision, and professionalism with our CEO respecting and taking care of us shareholders!
$BLEG
BLEG
Respectfully,
Maverick
STOKED Crazy horse! So happy you could find it and post it for others!
Perhaps DT GOODY or another MOD CNA pop it in IBOX!!
Woohoo!!
This Interview speaks VOLUMES!!
$BLEG
BLEG
Respectfully,
Maverick
AWESOME WORK CRAZY HORSE!!
Every investor and future investor need to see this!!
BREA $BREA
Brera Holdings PLC (NASDAQ:BREA) Short Interest Up 109.5% in February
Company chairman owns over half the O/S, Coordination owns another 25%...free float 397K
$BREA Name of Buyer: Daniel Joseph McClory Purchase Price: $1,500,000 Name of Seller: Niteroi SpA (Adrio Maria de Carolis) Date: February 29, 2024 Name of Issuer: Brera Holdings PLC Amount and Type of Securities: 2,250,000 Class A Ordinary Shares
sec.gov/Archives/edgar/data... Name of Buyer: Daniel Joseph McClory Purchase Price: $1,537,500 Name of Seller: Alessandro Aleotti Date: February 29, 2024 Name of Issuer: Brera Holdings PLC Amount and Type of Securities: 2,300,000 Class A Ordinary Shares sec.gov/Archives/edgar/data...
$BREA $3 break above Feb high and it's gone...chart is in the early stages of an extended explosive uptrend. Usually they throw up a sell block by now..tables are turning
Brea $BREA one of these low float amazing stocks that can run very highly with this A+ CEO, and BOARD OF DIRECTORS!!
See you in double digit land soon!!
These are the companies that EXPLODE upward in price per share and do forward splits in my humble opinion!
Reminds me when I got in $TASR TASR cheap and low float, and it exploded and forward split!
All my opinion, not financial advise!
What does the CEO know that he bought over 1/2 the float with the recent FORM 13G SEC!
I’m following the BIG $$ and my bet is to follow the actions of the CEO!
I’ve only got 10,000 shares , but it can and will bring me substantial return of investment in my opinion!
$BREA
BREA
Respectfully,
Maverick
It sure does smell....
SHORTS FRYING!!
$BREA
BREA
Respectfully,
Maverick
Make sure everyone google BRANDED LEGACY on YouTube!
Great interview with $BLEG CEO!
Worth the watch and paints a BEAUTY of a company being built with a STRONG BASE..
Brick by brick , assets, expansion, multiple products with outstanding reviews and PROFITABILITY INCOMING ASAP!!
$BLEG
BLEG
Respectfully,
Maverick
In for 10,000 shares $1.63 average!
Building powerhouse company!
Huge insider ownership!!
LOW FLOAT
MASSIVE POTENTIAL!!
BREA
$BREA
Respectfully,
Maverick
Love the board of directors and my DD shows SEVERELY UNDERVALUED!
Breaking out of triangle with $1.70 being resistance followed by
$2.15
Then onwards to $3.50 with retest of the $4.82 high!
Get to be part owner to of first public traded FUTBOL 🇺🇸
Absolutely!! Just collecting shares on to my stash here!! This is going NORTH, volume will come and it’s OFF TO THE RACES!
$BLEG
Respectfully,
Maverick
Filled 822,500 shares of a 865,000 order at .0019
$BLEG
THEY DONT HAVE SHARES!!
This is SUPER COILED!!
Golden cross ENROUTE!
Respectfully,
Maverick
They moved ask to .002
Mm fishing for shares
Absolutely crazy horse and interesting to find DD!
Here’s a YouTube video about a month ago interviewing our CEO!!
Mm know what coming and collecting shares in the bid!! Watch this!
Woohoo! I’m pumped up for $BLEG!! I’ve got nothing but time to let this mature into a BEAUTIFUL Company helping people!
There’s a great YouTube video with the CEO
MUST READ $BLEG
$BLEG "The addition of their high volume Critical CO2 extraction capabilities to our existing CO2 capacity is a crucial step in securing a major Kavalactone extraction and refinement contract. In turn we will employ our recently acquired topical and cosmetic packaging equipment as a huge cost saving measure to Sycamore BioPharm's operations. Together, our combined capabilities propel us to the forefront of innovation, ensuring the delivery of high-quality, scientifically-backed solutions that set new standards in the biotech industry!
Pounding fists here, this is the buy of the century!
REVOLUTIONIZE
$BLEG "This relocation signifies a pivotal moment for Branded Legacy, Inc. as we continue to advance our capabilities in the field of biotechnology," said David Oswald, CEO of Branded Legacy, Inc. "Our investment in cutting-edge scientific equipment has catalyzed our growth, and this new facility reinforces our dedication to advancing biotech solutions for the betterment of humanity."
The move to the new biotech facility underlines Branded Legacy, Inc.'s commitment to pushing the boundaries of biotechnology and improving the future of healthcare
$BLEG "CEO Dave Oswald had this to say about recent developments in the lab: "In the past, other companies were only scratching the surface in their efforts to extract and refine kavalactones. Prior to our team taking on the challenge of producing a superior product, the best the market had to offer was a decent purity level with an inconsistent opaque appearance. We were able to make a high purity extract that was completely translucent and very flavorful on the first day. When we presented our extract to our kava suppliers, they asked to move forward immediately with a white label contract. Needless to say, we are very excited about the potential of these developments!!
One day!! Holy smokes !!
$BLEG
Good night all, all in my opinion!
We are going to REVOLUTIONIZE this industry!!
W O W !
Respectfully,
Maverick
Mzasif!! THANKS for all your posts, research and due diligence! I read every post of yours and LOVE YOUR PASSION!
This is $BLEG time and our time!
Ground floor of MASSIVE COMPANY in making at bottom prices in my opinion!
Respect you, and your INCREDIBLE DUE DILIGENCE, and being a TEAM PLAYER to share it with fellow investors!
I’m truly amazed at our price, and that’s changing very quickly to the upside and get proper price appreciation to reflect our EXCELLENT PROGRESS here with BRANDED LEGACY!
Teamwork makes the dream work!
I am in 100% locked, loaded and KNOW we are going SUPER SONIC here with $BLEG!
Thank you so much for your hard work, your phone calls and then being a COOL INVESTOR and sharing it with other investors on the board!
A+
Have a BLESSED night!
Respectfully,
Maverick
$BLEG
BGC,
$BLEG, yes, I humbly believe we are going to “SKYROCKET” to copper and silver, never looking back!
Here’s some cool DD I found on STOCKTWITS from a INVESTOR named IRON SHARPENED.
$BLEG Coming up:
- More contracts for existing products
- Contracts to sell Sycamore acquired inventory
- More white label contracts
- Change to new name/symbol
- Q4 2023, end of yr and Q1 2024 fins
- Start of clinical trials for Bio products
- Intro of new products
- Possibly 4 more acquisitions
Furthermore:
BLEG "The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. " Meet rising demand....
BLEG "EMBRACED™ collection is set to revolutionize the topical delivery of CBD and other active botanical ingredients." from Sycamore Biopharm. They are embedded with the University of South Carolina Medical college
This is HUGE!!
$BLEG
$BLEG "This acquisition comes at a great time as Branded Legacy has recently signed several large white label manufacturing deals, ensuring throughput and creating a clear path to profitability
When BRANDED LEGACY does a PR on this white label contracts , this stock is SCREAMING to pennyland!
BLEG Keep in mind, every product on the market that contains Kava will want the clearest version. BLEG is the only company w/ 100% clear Kava. The clarity means no mixing or taste altering issues w/ the solution it is being mixed with. Any particles that are in a non clear version alter the color and taste and solubility. BLEG can the command a higher price for their product over their competitors
So many amazing points this investor brings up!!
I wish we could get him or her over here on the IHUB BOARD!
$BLEG More from MZASIF from IHUB...
"He also stated that Q3 financials should come out sooner than later before the due date which is end of March and also that in their company is in negotiation with 4 different companies at this present time (HUGE NEWS) and every deal that does take place will be done through Preferred Shares.
On my further inquiry (just for my knowledge), he stated their primary business (products) are HEMP based (non -THC) but the All-In-Extracts LLC that they recently acquired does carry some THC level recreational products.
He has welcomed anyone to reach out to him (his company) if they ever have a concern.
The number he called me from was 877 814 488 whereas, I left him a message with his compliance officer Phil White at 321 345 3565 shown in OTCM
So these are few bits of nice information I got from STOCKTWITS and wanted to share it with you investors here on IHUB!
GLTA
Respectfully,
Maverick
$BLEG
BLEG
Everything coming to fruition with this CEO NEWSLETTER!
Must read for everyone.line by line!
$BLEG
BLEG
Respectfully, Maverick
Slow and steady, higher highs and higher lows DT!!
$BLEG
BLEG
Beautiful A/D LINE!
Stair stepping it’s way preparing for GOLDEN CROSS!
Diamond hands here! This has MAJOR POTENTIAL!!
$BLEG
BLEG
Respectfully,
Maverick
Absolutely crazy horse!!
ALERT$$$$$$$
Golden cross INBOUND for $BLEG!
BLEG
Respectfully,
Maverick
Thanks Chanel trader! Great looking chart!
$BLEG
BLEG
Respectfully,
Maverick
So TRUE BGC!! PAY TIENCE is coming in. HUGE with $BLEG BLEG
Respectfully,
Maverick
Exactly BGC, YOU said it so simply! I’m just AMAZED how cheap $BLEG is and NOT for long!
This is bottom and I’m having family and friends get in ASAP!
What a DIAMOND HAND GEM $BLEG IS!!
Congrats!
Respectfully,
Maverick
Thanks swim and keep up the EXCELLENT POSTS! I’m getting family and friends in this company ASAP!
$BLEG
BLEG
RESPECTFULLY,
Maverick
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
LITERALLY IN SHOCK,
READ EVERY LINE PEOPLE
Shouting in ALL CAPS!
This DR whose head of our division is A+ and WELL KNOWN!
As BGC says “SUPER GOLDEN!” I say we are “SUPER PLATINUM” with $BLEG!
Read every line!! Takes my breath away!!
GO BLEG $BLEG
RESPECTFULLY,
Maverick
Onward, upward, stair stepping BEAUTY CHART FOR $BLEG biochem!!
SUPER BULLISH!!
BLEG $BLEG
ALL MY OPINION!
Respectfully,
Maverick
Mzasif,
EXACTLY!!
$BLEG wound up, GOLDEN CROSS incoming accumulation / distribution AWESOME
We are better than the other company and soon will surpass it in share price in my opinion!
$KBLB
$BLEG better share structure , management , products and acquisitions than $KBLB!
Share price of $BLEG about to SUPERSONIC MACH 8 to catch KBLB $KBLB in my opinion!
Respectfully,
Maverick
By the way.. keep up the SOLID POSTS, nice enthusiasm and due diligence, much APPRECIATED!
Absolutely and ITS on when we do that Brother!!
$BLEG LONG
RESPECTFULLY,
Maverick
That’s AWESOME! I’m looking forward to when shareholders get the invitation to HEADQUARTERS there in Florida! I will fly out and visit $BLEG headquarters!!
I’m very IMPRESSED with all the due diligence everyone has provided, in a cool, professional manner where future investors may:
Make a informed, educated decision on the knowledge, skills and abilities of our current CEO, BLEG $BLEG company etc.
It’s like working out is what I reference $BLEG to!
Many people go and only workout UPPER BODY, failing to build a base which is STRONG CORE, STRONG GLUTES, QUADS, HAMSTRINGS and calf muscles!
YOU MUST BUILD A STRONG BASE “lower body” before building upper body etc!
$BLEG is building a GIGANTIC STRONG BASE..
Share retirements, lockout agreements with all officers , putting perfect acquisitions together to complement each other..
We just moved from 4,000 to 11,000 square foot manufacturing facility!
As mzasif poster said :
Bring us the WHITE LABEL CONTRACTS!
We have ASSETS, real ASSETS, real products and a A+ MANAGEMENT TEAM, executing a SOLID BASE to grow leaps and bounds each and every sequential quarter in revenues, product offerings and roll it out through ESTABLISHED DISTRIBUTION CHANNELS !
Talk about methodical, precision guided FOCUSSED MANAGEMENT, that first and foremost is one of the MOST SHAREHOLDER FRIENDLY MANAGEMENT IN THE OTC!
LOW FLOAT
NO DILLUTION
$1 million credit line FAVORABLE TERMS
MASSIVE SHARE REDUCTIONS IN A/S, O/S AND small float of 440 million roughly with DEBT being cleared with exception of roughly $21,000 and products selling !
NEW PRODUCTS INBOUND , ASSETS not LIABILITIES...
PROFIT is coming in my opinion in a HUGE WAY!
True example of patience will be PAY TIENCE as your targets of .50 and $1.00 will come with PROVEN PROFITS, as we expand nationwide in my opinion!!
.03-.05 will come quickly and love these prices to have family, friends LOCK UP this NANO FLOAT!
I am SHOCKED at such a deal .002 for such a AMAZING COMPANY, SOLID BUSINESS PLAN and EXECUTING SOLID BASE to go THERMONUCLEAR UTILIZING our incredible talented CEO, employees and relationships to show BRANDED LEGACY is here and operating on all cylinders!
Here’s to SUCCESS for BRANDED LEGACY, and all shareholders!
These prices will be HISTORY very soon!
Proud of my position and continuing to add at these GIFTED LEVELS!
$BLEG
RESPECTFULLY,
Maverick
Sharky,
We are at the right place, right time... plain, pure and simple with $BLEG!
This is MASSIVE news that will just add to the rocketship here!
This is trading so clean, and AMAZED at the silly market cap so far!! The market will correct it to FURTHER UPSIDE as their are so many positives with $BLEG!
See you in copper and silver land soon with $BLEG!
GOLDEN CROSS INCOMING!!!!
All my opinion!
Respectfully,
Maverick
Thanks crazy horse, and GREAT DD! I’ve let the BB crowd and MOMO crowd know of this gem with $BLEG BLEG!
Maverick
Yes!! The 50/200 dMA coming together to create the MOST BULLISH TECHNICAL move...
$BLEG BLEG GOLDEN CROSS
BEAUTIFUL chart, higher highs, higher lows!
INCREDIBLE share structure and SUPER TRANSPARENT CEO!
The crowds will find this and accumulation / distribution looks AMAZING!!
A/D LINE
YUMMY!
This is of course without any additional bullish news !
This company is SEVERELY UNDERVALUED!
Some of my friends in $IFUS IFUS coming over!
My opinion is this BLOWS past .0043 on Golden cross to COPPER with little to no resistance!
This company is worth 1.3 cents just in assets from the companies they have acquired with products on the shelf’s and incredible share reductions!
So many CEO promise to reduce shares etc this CEO is kicking some serious butt and does it through “ TANGIBLE ACTIONS!”
Actions SPEAK louder than words and this CEO has PROVED IT!
$BLEG is doing it correctly and one of the BEST CEO down here doing it!
All my opinion!!
Respectfully,
Maverick
All my opinion
LOCK THIS SUB FLOAT
MY opinion not financial advise.
I feel these million shares for $2,000 will be worth $50,000 in the not to distant future!!
Going to he getting 10k, financials and more updates!!
YES!!
So FUN TO FIND INCREDIBLE DD, and verify it!!
BLEG $BLEG
Absolutely GOLDEN CROSS!!
$BLEG $CBMJ monsters!!
Love Golden crosses!!
Respectfully,
Maverick
BLEG $BLEG .002 BEST SUB out here!
COURTESY of crazy horse!!
ews Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc.
https://nz.finance.yahoo.com/news/branded-legacy-inc-significantly-expands-145000503.html
https://sycamorebp.com/our-story/
"Company Prepares for Clinical Trials with Esteemed Addition: Dr. Mark T. Hamann, Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy"
MELBOURNE, Fla., March 12, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a trailblazing BioTech holdings company, proudly announces the strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union.
Renowned for its meticulous development of wellness solutions, ranging from gummies to compression sleeves and pain-relieving topical creams, Sycamore BioPharma has earned acclaim as a prolific product developer. The acquisition brings forth over $500,000 in high-quality, ready-to-sell inventory and aligns seamlessly with Branded Legacy's dedication to quality, authenticity, and a commitment to natural ingredients.
David Oswald, CEO at Branded Legacy, Inc., expresses enthusiasm about the acquisition, stating, "Branded Legacy is thrilled to embrace Sycamore BioPharma into our family of companies. This tactical move not only compliments our existing portfolio, but also brings us several steps closer to our goal of achieving FDA approval for several of our pharmaceutical products.."
The acquisition not only opens new markets for Sycamore BioPharma but also provides access to Branded Legacy's extensive network, enhancing the company's ability to connect with consumers, build brand loyalty, and drive sales growth. It was also a crucial step in securing and maintaining a slew of large white label manufacturing and extraction contracts.
Tyler Stone, President of Sycamore Biopharma, Inc., is also enthusiastic about the acquisition stating, "Branded Legacy brings significant strengths in areas where Sycamore BioPharma was seeing significant challenges. Their network and consumer outreach will undoubtedly drive sales growth of our innovative products and we are proud to be a part of the Branded Legacy network of companies."
The collaboration between Branded Legacy and Sycamore BioPharma is poised to unlock synergies across various business facets. Leveraging Branded Legacy's web properties, brand management, and marketing expertise, the integration aims to maximize the reach and impact of Sycamore BioPharma's groundbreaking wellness solutions. Furthermore, the addition of Dr. Mark Hamann, a PHD holding scientist, to Branded Legacy's roster will enhance efforts in developing novel pharmaceuticals and streamline the FDA approval process, particularly in clinical trials.
Dr. Mark T. Hamann, the newly appointed Director of Clinical Trials at Branded Legacy, brings a wealth of expertise as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina College of Pharmacy. Holding Adjunct appointments with The University of Maryland's Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine, Dr. Hamann's distinguished career commenced in GMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota.
Throughout his career, Dr. Hamann has authored over 250 scientific papers, reviews, and book chapters, while mentoring over 100 graduate students, postdoctoral fellows, and visiting scholars. Dr. Hamann's graduate studies led to the discovery of the anticancer agent, kahalalide F, which advanced to clinical trials in collaboration with biotech company PharmaMar. Currently serving as an Associate Editor for Biochimica et Biophysica Acta, General Subjects, Dr. Hamann's research group is actively engaged in the isolation, structure determination, and synthesis optimization of natural products and toxins. Their focus on plant and invertebrate microbiomes aligns with Branded Legacy's commitment to sustainable pharmaceutical development.
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
For more information about Sycamore BioPharma, Inc, please visit: https://sycamorebp.com/
Original Copy of this Press Release:
https://brandedlegacy.com/branded-legacy-inc-elevates-biotech-presence-through-successful-acquisition-of-sycamore-biopharma-inc
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
Cision
Cision
View original content:https://www.prnewswire.com/news-releases/branded-legacy-inc-significantly-expands-asset-portfolio-and-production-capacity-through-successful-acquisition-of-sycamore-biopharma-inc-302086890.html
SOURCE Branded Legacy Inc.
BLEG $BLEG .002 BEST SUB stock period!!
ews Branded Legacy, Inc. Significantly Expands Asset Portfolio and Production Capacity Through Successful Acquisition of Sycamore BioPharma, Inc.
https://nz.finance.yahoo.com/news/branded-legacy-inc-significantly-expands-145000503.html
https://sycamorebp.com/our-story/
"Company Prepares for Clinical Trials with Esteemed Addition: Dr. Mark T. Hamann, Endowed Chair of Drug Discovery and Biomedical Sciences at the MUSC College of Pharmacy"
MELBOURNE, Fla., March 12, 2024 /PRNewswire/ -- Branded Legacy (OTC.PK: BLEG), Inc., a trailblazing BioTech holdings company, proudly announces the strategic acquisition of Sycamore BioPharma, Inc, a distinguished developer of plant-based pharmaceuticals. This strategic milestone not only fortifies Branded Legacy's standing as a prominent player in the biotech sector but also secures assets exceeding $2 million, along with key personnel crucial for advancing clinical trials following this successful union.
Renowned for its meticulous development of wellness solutions, ranging from gummies to compression sleeves and pain-relieving topical creams, Sycamore BioPharma has earned acclaim as a prolific product developer. The acquisition brings forth over $500,000 in high-quality, ready-to-sell inventory and aligns seamlessly with Branded Legacy's dedication to quality, authenticity, and a commitment to natural ingredients.
David Oswald, CEO at Branded Legacy, Inc., expresses enthusiasm about the acquisition, stating, "Branded Legacy is thrilled to embrace Sycamore BioPharma into our family of companies. This tactical move not only compliments our existing portfolio, but also brings us several steps closer to our goal of achieving FDA approval for several of our pharmaceutical products.."
The acquisition not only opens new markets for Sycamore BioPharma but also provides access to Branded Legacy's extensive network, enhancing the company's ability to connect with consumers, build brand loyalty, and drive sales growth. It was also a crucial step in securing and maintaining a slew of large white label manufacturing and extraction contracts.
Tyler Stone, President of Sycamore Biopharma, Inc., is also enthusiastic about the acquisition stating, "Branded Legacy brings significant strengths in areas where Sycamore BioPharma was seeing significant challenges. Their network and consumer outreach will undoubtedly drive sales growth of our innovative products and we are proud to be a part of the Branded Legacy network of companies."
The collaboration between Branded Legacy and Sycamore BioPharma is poised to unlock synergies across various business facets. Leveraging Branded Legacy's web properties, brand management, and marketing expertise, the integration aims to maximize the reach and impact of Sycamore BioPharma's groundbreaking wellness solutions. Furthermore, the addition of Dr. Mark Hamann, a PHD holding scientist, to Branded Legacy's roster will enhance efforts in developing novel pharmaceuticals and streamline the FDA approval process, particularly in clinical trials.
Dr. Mark T. Hamann, the newly appointed Director of Clinical Trials at Branded Legacy, brings a wealth of expertise as the Charles and Carol Cooper/SmartState Endowed Chair of Drug Discovery and Biomedical Sciences at the Medical University of South Carolina College of Pharmacy. Holding Adjunct appointments with The University of Maryland's Institute of Marine and Environmental Technology and the Bigelow Marine Laboratory in Maine, Dr. Hamann's distinguished career commenced in GMP pharmaceutical manufacturing at Solvay Pharmaceuticals in Baudette, Minnesota.
Throughout his career, Dr. Hamann has authored over 250 scientific papers, reviews, and book chapters, while mentoring over 100 graduate students, postdoctoral fellows, and visiting scholars. Dr. Hamann's graduate studies led to the discovery of the anticancer agent, kahalalide F, which advanced to clinical trials in collaboration with biotech company PharmaMar. Currently serving as an Associate Editor for Biochimica et Biophysica Acta, General Subjects, Dr. Hamann's research group is actively engaged in the isolation, structure determination, and synthesis optimization of natural products and toxins. Their focus on plant and invertebrate microbiomes aligns with Branded Legacy's commitment to sustainable pharmaceutical development.
Dr. Hamann's ongoing projects include the preclinical development of a small pipeline of natural products with potential applications against cancer, emerging infectious diseases, and neuropsychiatric disorders. His extensive experience and dedication to advancing scientific frontiers make him a valuable addition to Branded Legacy's mission to deliver high-quality, scientifically-backed solutions in the biotech industry. Branded Legacy has already begun supplying the Medical University of South Carolina with samples of mitragynine extract in order to build an effective experimental design for addiction mitigation. Although these trials are arduous, Branded Legacy is committed to doing whatever is necessary to support the process and offer these therapies to the patients who need them as quickly as possible
In other company news, Branded Legacy has just completed a move to a significantly larger facility, accommodating the expanding operations and facilitating enhanced capabilities. The move comes in tandem with the acquisition of millions of dollars worth of state-of-the-art scientific and extraction equipment, solidifying Branded Legacy's commitment to staying at the forefront of innovation in the biotech industry.
The new facility not only provides increased space for research and development but also positions Branded Legacy to meet the rising demand for its innovative wellness solutions. The acquisition of advanced scientific and extraction equipment further strengthens the company's technological infrastructure, supporting its endeavors in drug discovery, pharmaceutical development, and the optimization of natural products.
For more information about Sycamore BioPharma, Inc, please visit: https://sycamorebp.com/
Original Copy of this Press Release:
https://brandedlegacy.com/branded-legacy-inc-elevates-biotech-presence-through-successful-acquisition-of-sycamore-biopharma-inc
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings company focused on the biotech sector. With a commitment to excellence and innovation, Branded Legacy specializes in the development and marketing of cutting-edge products and services, including ventures in biotechnology, digital solutions, and wellness products.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, subject to risks and uncertainties that could cause actual results to differ materially from current expectations. The company disclaims any intention or obligation to update or revise forward-looking statements. Forward-looking statements may be identified by words such as "may," "will," "expect," "believe," "anticipate," "estimate," and similar expressions.
Cision
Cision
View original content:https://www.prnewswire.com/news-releases/branded-legacy-inc-significantly-expands-asset-portfolio-and-production-capacity-through-successful-acquisition-of-sycamore-biopharma-inc-302086890.html
SOURCE Branded Legacy Inc.
Incredible Janet !!
$BLEG
Crazy horse,
Incredible DD sticky post!! This is so UNDERVALUED, and EXCELLENT CEO!
$BLEG belongs multi copper at a minimum once all the $$ comes from OTC traders chasing bitcoin!
SUPER DD POST!
May I copy and paste this great DD post you compiled with credit to you to other boards?
Seems we need to let others know what a gem we have! $$$
Going to pour more of my $FF FF profits in here!
Great work CRAZY HORSE!!
Respectfully,
Maverick
$BLEG
BLEG
BLEG $BLEG
.002
Major company here with lots going for it!
Technicals setting up for 50/200 dMA GOLDEN CROSS!
Undervalued, no dilution , and ready for making higher highs after .0043!!
BLEG
$BLEG
BLEG $BLEG.002
Major company here with lots going for it!
Technicals setting up for 50/200 dMA GOLDEN CROSS!
Undervalued, no dilution , and ready for making higher highs after .0043!!
BLEG
$BLEG
$BLEG GOLDEN CROSS inbound!